The short answer
Short studies in healthy people suggest that repeated higher-dose aspirin can affect gastric or measured vitamin C status, and vitamin C changed some gastric or duodenal injury measures. These findings support considering adequate intake in people with poor intake or repeated higher-dose exposure. They do not establish clinical vitamin C deficiency, routine testing, megadose treatment, or prevention of major bleeding or ulcers.
What this answer covers
Evidence is short-term and mostly higher-dose aspirin. It does not establish a vitamin C requirement for all 81 mg or 100 mg aspirin users.
- Supplement or preparation
- Vitamin C
- Medication ingredient
- aspirin
Measured vitamin C change was short term
In 45 healthy subjects, the initial regimen of aspirin 0.8 g three times daily lasted six days. The aspirin-only group had lower gastric-mucosal, plasma, and urine ascorbate at day 7, and the authors describe about a 10% gastric-mucosal reduction. The protocol later switched treatments without washout, but the abstract does not state a fixed second six-day exposure period.
Gastric findings are not all the same
One three-day volunteer study reported that vitamin C attenuated aspirin-associated gastric damage with aspirin 400 mg twice daily and vitamin C 480 mg twice daily. Another used aspirin 900 mg twice daily and vitamin C 1 g twice daily. In that crossover study, vitamin C did not reduce any gastric-injury parameter, while it reduced duodenal injury by Lanza score.
What these studies cannot promise
None of the reviewed studies establishes clinical vitamin C deficiency, routine laboratory testing, or an aspirin regimen for everyone. They also do not show that vitamin C prevents major gastrointestinal bleeding, replaces evidence-based ulcer treatment, or makes higher-dose aspirin safe. Their short duration and healthy-volunteer populations set clear limits.
What this means for use
For someone with poor intake or repeated higher-dose aspirin exposure, adequate dietary vitamin C is a reasonable topic to discuss with a clinician. Do not treat the study doses as a recommended consumer dose. The current low-dose aspirin label names black stools, vomiting blood, persistent stomach pain, and faintness as warning signs that need urgent medical evaluation.
Evidence and practical considerations
Timing & monitoring
Adequate vitamin C intake may be considered with repeated higher-dose aspirin or poor intake, but routine vitamin C testing or supplementation for all aspirin users is not established.
- Exact scope
- Vitamin C 480 mg twice daily or 1 g twice daily in direct co-use studies; no general megadose recommendation. with Repeated higher-dose aspirin regimens of 400 mg twice daily, 800 mg three times daily, or 900 mg twice daily in short studies.
- Medication form and route
- oral aspirin regimens as reported
- Timing or duration
- Three to six days of initial higher-dose exposure.
What remains uncertain
- Healthy short-study biomarker and surrogate endpoints; mixed gastric versus duodenal result; no clinical deficiency or major-bleed prevention endpoint.
Factors that may matter: poor dietary intake; repeated higher-dose aspirin exposure; gastrointestinal symptoms requiring clinical assessment.
Read the supporting source summaries
Source 1: randomized double-blind study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 45 healthy subjects in three groups of 15.
ASA-only group had reduced gastric-mucosal, plasma, and urine ascorbate at day 7; authors report about 10% lower gastric-mucosal ascorbate within six days.
How this applies: Direct higher-dose aspirin and vitamin-C biomarker evidence only.
Short healthy-subject biomarker study; no stated fixed post-switch duration, no clinical deficiency outcome, and no preventive-dose comparison.
Source 2: human gastric injury study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Human volunteers; sample size not reported in abstract.
Vitamin C significantly attenuated reported gastric damage and reversed measured aspirin-associated changes.
How this applies: Direct co-use gastric endpoint evidence only.
Abstract omits sample size and numeric effects; short surrogate gastric study; no major-bleed or ulcer-treatment endpoint.
Source 3: double-blind randomized crossover study
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 14 healthy volunteers, seven male, mean age 27 years.
No drug reduced any gastric-injury parameter; vitamin C reduced duodenal injury by Lanza score (P<.005).
How this applies: Direct co-use evidence with endpoint-specific null and positive findings.
Abstract-level extraction only; small, short healthy-volunteer study; gastric and duodenal results differ; no major bleeding or ulcer-treatment outcome.
Source 4: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Users of this labeled 81 mg enteric-coated aspirin product.
Warns of severe stomach bleeding and names faintness, vomiting blood, bloody or black stools, and persistent stomach pain as warning signs.
How this applies: Medication safety context for gastrointestinal symptoms, separate from vitamin C efficacy.
Product-label warning; it does not establish a vitamin C regimen or a preventive effect from vitamin C.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Private package prepared without clinical approval or release. | |
| Research summary published |
Article revision: 335b33995e3e8585
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.